by QuantuMDx Team | Apr 7, 2022 | News
NEWCASTLE UPON TYNE, UK, 01 APRIL 2022. QuantuMDx Group Limited (“QuantuMDx”), is pleased to announce that it has won two Bionow Awards 2021, which took place last night, Thursday 31 March 2022. The company was shortlisted for three awards, winning two in total. The...
by QuantuMDx Team | Feb 22, 2022 | News
NEWCASTLE UPON TYNE, UK, 22 FEBRUARY 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its rapid PCR SARS-CoV-2 test, with the multiplex Q-POC™ platform, has been approved for continued sales in the UK under the UK Health Security Agency’s Medical...
by QuantuMDx Team | Feb 10, 2022 | Blog
Last week QuantuMDx achieved yet another milestone by introducing Laboratory Information System (LIS) connectivity to the Q-POC™ software. The latest software release for the Q-POC™ platform, 3.2, is a significant upgrade that enables test records to be...
by QuantuMDx Team | Nov 26, 2021 | News
NEWCASTLE UPON TYNE, UK, 26 NOVEMBER 2021. QuantuMDx Group Limited (“QuantuMDx”), today confirms that both its SARS-CoV-2 assays for open PCR platforms and its rapid PCR device, Q-POC™, as well as its future respiratory panel (SARS-CoV-2, Flu A, Flu B and RSV A/B),...
by QuantuMDx Team | Aug 16, 2021 | News
Providing a rapid, PCR COVID-19 testing solution to the UK film & TV industry NEWCASTLE UPON TYNE, UK, 16 August 2021. QuantuMDx has announced it is partnering with Cignpost Diagnostics, (‘Cignpost’), a leading provider of COVID-19 workplace testing to the...
